Shorter time from leukapheresis to infusion of axi-cel corresponds to better CR and OS in r/r LBCL patients

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1

ASH 2022: Multiple myeloma roundup

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML

Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery

Updates from TAILORx and RxPONDER: Implications for practice

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery

Maximising cancer treatment and research through omics, data sharing, and open science

Epidemiology, detection, and management of NAFLD: a Latin American perspective

Optimisation of supportive, palliative and end of life care

What is required to advance data ethics, data sharing, and Open Science across LMICs

Breast cancer in elderly patients: a clinicopathological review of a Nigerian database